Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1993-03-04
1995-12-19
Knode, Marian C.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
43524021, 4352401, C12N 500
Patent
active
054767806
DESCRIPTION:
BRIEF SUMMARY
TECHNICAL FIELD
The present invention relates to a method for culturing T lineage precursor cells, which enables derivation and generation of matured T cells differentiated from the T lineage precursor cells. The invention further relates to T cells obtained by using this method.
BACKGROUND ART
The earliest of T cells exist mainly in bone marrow or fetal liver, as a form of lymphoid stem cells differentiated from hematopoietic stem cells having an ability to differentiate into multilineage cells. These earliest stem cells emigrate to the thymus and mature into T cells through a series of differentiation stages. The differentiation and maturation of the T precursor cells are greatly under the influence of thymic stromal cells. After T precursor cells enter into the thymic cortex, the T precursor cells differentiate and mature into T cells through rapid cell division and proliferation under the control of adhesion with stromal cells comprising mainly thymic epithelial cells which participate in differentiation and maturation of the T precursor cells, adhesion with myeloid cells such as macrophages, and humoral factors produced therefrom. After undergoing several differentiation stages thymocytes flow out to the bloodstream from the cortico-medullary junction of thymus, and emigrate to peripheral lymphoid organs. The emigrated thymocytes, i.e., T cells, further differentiate and mature therein.
To study the detailed process of differentiation and maturation of the T precursor cells, a culture system capable of achieving in-vitro proliferation, differentiation, and maturation of T cells is required.
On the other hand, it is considered that abnormality of differentiation or of functions of T cells due to immunization with infectious bacteria and/or an foreign antigen is one great cause of allergic diseases or various autoimmune diseases. (e.g., Animesh A. et al, Science, Vol. 248, 1380-1388, 1990; Irun R. Cohen et al, Immunology Today, Vol. 12, No. 4, 105-110, 1991; and Lars Klareskog et al, Immunological Reviews, Vol. 118, 285-310, 1990).
At present, as therapeutic drugs for such diseases, non-specific anti-inflammatory agents and immunosuppressants of T cell functions are used as suppressors. However, essential cure of the diseases has not been achieved due to their non-specificity.
To overcome these problems, extensive studies on vaccine therapy and serum vaccine therapy have been made, comprising respectively (1) specifying an antigen which causes disease and applying the antigen, and (2) specifying said antigen and applying suppressive factors specific for the diseases which are represented by antibodies against the antigen. A cell vaccine therapy using T cells whose antigen specificities has been proved is considered to be an effective therapeutic method for diseases which is assumed to be caused by abnormal differentiation and functional abnormality of T cells (e.g., Jose C. Gutierrez-Ramos et al, Nature, Vol. 346, 271-274, 1990 and Kohei Ota et al, Nature, Vol. 346, 183-187, 1990). However, methods capable of deriving T cells having appropriate antigen specificity in vitro are limited to a particular method.
In fact, although a submerged (suspension) culture in which cells or tissues are submerged or suspended in a nutrient medium is well known as a method generally used for culture of cells or tissues, it is impossible to differentiate and mature T precursor cells into T cells in accordance with such a conventional method.
At present, as the sole culture method capable of achieving differentiation and maturation of the T precursor cells, only a so-called afloat culture is known, in which a fetal thymus is cultured on an interface between the gas phase and the nutrient medium under atmospheric air whose carbon dioxide concentration is controlled to 5% (e.g., Jenkinsen E. J. et al, Eur. J. Immunology, Vol. 12, 583, 1982 and Osamu Mazda et al, J. Exp. Med., Vol. 173, 539-547, 1991). However, this method requires special tools or apparatuses, and differentiation of cells on the liquid surface side is i
REFERENCES:
patent: 4284724 (1981-08-01), Fukuda
patent: 4448879 (1984-05-01), Fabricius
patent: 4649114 (1987-03-01), Miltenburger
patent: 4720462 (1988-01-01), Rosenson
patent: 5147784 (1992-09-01), Peault
Muench et al, Cytokine, vol. 4, No. 6, pp. 488-494 (Nov. 1992).
Oller et al, J. of Cell Science, vol. 94, pp. 43-49 (1989).
Smith et al., British Journal of Haematology, vol. 63, pp. 29-34 (1981).
Palsson et al, Bio/Technology, vol. 11, pp. 368-372 (Mar. 1993).
Aparicio, P. et al, "Isolation and Characterization of (.gamma..alpha.)C1)4.sup.+ T Cell Clones Derived from Human Fetal Liver Cells", J. Exp. Med. vol. 170, pp. 1009-1014, 1989.
Leclercq, G. et al., "Preferential Proliferation of T Cell Receptor V .gamma.3-Positive Cells in IL-2 Stimulated Fetal Thymocytes", vol. 145, No. 12, pp. 3992-3997, 1990.
Galili et al. "Human Prothymocytes", J. Exp. Med., vol. 152, pp. 796-807, 1980.
Green et al., "Production and Characterization of Human T-Cell Hybrids Exhibiting Suppressor Cell Activity", Clinical Research, vol. 29, No. 2, 368A, 1989.
Ceredig, R. et al., "Mouse Fetal Thymus Lobes Cultered in II-2 Generated CD3.sup.+, TCR-.gamma. .alpha.-Expressing CD4-/CD8.sup.+ and CD4-/CD8-Cells," J. Immun. vol. 142 No. 10, 1989, pp. 3353-3360.
Cattermale, J. et al., "Isolation of Murine Fetal Thymus Cell Lines After Infection with Recombinant Retroviruses Containing the V-Myc and D-Ha-ras Ancogenes", J. Immu. vol. 142, No. 11, 1989 pp. 3746-3753.
Kingston et al., Nature, vol. 317, pp. 811-813 (1985).
PCT/US89/02233, filed May 22, 1989 "Growth Of Animal Cells At High Oxygen Concentration" Effect of Deoxyguanosine on lymphopoiesis In The Developing Thymus Rudiment In Vitro: Application In The Production Of Chemeric Thymus Rudiments Eur. J. Immunol. 1982, 12:583-587.
"Requirement Of Dendritic Cells And B Cells In the Clonal Deletion Of Mls-Reactive T cells In The Thyms" By Osam Mazda, et al. Rockefeller Univ. Press, vol. 173 Mar. 1991-pp. 539-547.
"Autoimmune Diseases: The Failure of Self Tolerance" by Animesh A. Sinha et al Science vol. 248, Jun. 1990.
"Autoimmunity to Collagen II and Myelin Basic Protein: Comparative Studies in Humans & Rodents" by Lars Klareskog & Tomas Olsson, Immunological Reviews 1990, No. 118.
"Autoimmunity, Microbial Immunity And The Immunological Homunculus" by Irun R. Cohen & Douglas B. Young, Immunology Today, vol. 12, No. 4, 1991.
"T-cell Recognition of an Immuno-dominant Myelin Basic Protein Epitope in Multiple Sclerosis" by Kohei Ota et al-Nature, vol. 346, Jul. 12, 1990.
"Recovery from autoimmunity of MRL/lpr Mice After Infection with an Interleukin-2/Vaccinia Recombinant Virus", Jose C. Gutierrez-Ramos et al-Nature vol. 346 Jul. 19, 1990.
Dadio Susan M.
Japan Tobacco Inc.
Knode Marian C.
LandOfFree
Method for culturing T precursor cells under conditions of high does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for culturing T precursor cells under conditions of high , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for culturing T precursor cells under conditions of high will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-991669